Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 595 of 1,261
  1. US 9827228

    Opioid receptor modulators and use thereof

    Regents of the University of Minnesota · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  2. PT 2114927

    PROCESS FOR THE PREPARATION OF (R)-5-(2-AMINOETHYL)-1-(6,8-DIFLUOROCHROMAN-3-YL)-1,3-DIHYDROIMIDAZOLE-2-THIONE

    BIAL-PORTELA & Cª S A [PT] · Granted Nov 24, 2017 · Expires Nov 19, 2037

    granted
  3. US 9822117

    Pyridoindolobenz[b,d]azepine derivatives and uses thereof

    DAYA DRUG DISCOVERIES, INC. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  4. US 9820951

    Pulmonary disease treatment and diagnosis based on Arhgef1

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  5. US 9820952

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  6. US 9820970

    Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing viruses

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  7. US 9821054

    Method of vaccination comprising a histone deacetylase inhibitor

    TURNSTONE LIMITED PARTNERSHIP · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  8. US 9822162

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  9. US 9822365

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  10. US 9822184

    DCLK1 short form specific binding agents

    The Board of Regents of the University of Texas System · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  11. US 9822157

    Hepcidin analogues and uses thereof

    Protagonist Therapeutics, Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  12. US 9822068

    Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  13. US 9821075

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  14. US 9821030

    LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  15. US 9821049

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  16. US 9821029

    Methods of reducing salmonella in poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  17. US 9821023

    Methods for the treatment of central nervous system (CNS) disorders and mood disorders

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  18. US 9821019

    Compositions and methods for treatment of pain

    Princeton Biotechnology Corporation · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  19. US 9821012

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  20. US 9821006

    Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

    The Board of Regents of the University of Texas System · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  21. US 9820991

    Pharmaceutical composition comprising brinzolamide

    SENTISS PHARMA PRIVATE LIMITED · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  22. US 9820986

    Glycopeptide compositions

    The Board of Regents of the University of Texas System · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  23. US 9820966

    Stabilized statin formulations

    Cumberland Pharmaceuticals Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  24. US 9820965

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.